DEUTSCHE BANK AG\

Bank

Position in FTRE — Fortrea Holdings Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in FTRE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$24,308,722

+$106,161 QoQ

Shares Held

1,397,053

-45.6% QoQ

Ownership

1.47%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#19

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. FTRE ranks #16 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,308,722	1,397,053	-45.6%	Shares	Other	2026-08-07
2026-03-31	$24,202,561	2,569,274	+0.5%	Shares	Other	2026-05-06
2025-12-31	$44,094,329	2,556,193	+0.3%	Shares	Other	2026-02-11
2025-09-30	$21,458,437	2,548,508	+56.6%	Shares	Other	2025-11-13
2025-06-30	$8,041,518	1,627,838	+39.7%	Shares	Defined	2025-08-12
2025-03-31	$8,796,399	1,165,086	+17183.6%	Shares	Other	2025-05-09
2024-12-31	$125,719	6,741	-31.9%	Shares	Other	2025-06-30
2024-09-30	$197,840	9,892	+0.5%	Shares	Other	2025-06-26
2024-06-30	$229,642	9,839	-35.5%	Shares	Other	2025-06-12
2024-03-31	$612,776	15,266	-0.5%	Shares	Defined	2025-06-02
2023-12-31	$535,609	15,347	+20.2%	Shares	Defined	2024-02-14
2023-09-30	$365,007	12,767	—	Shares	Defined	2023-11-24
No filing history on record for this holder in this stock.